Clinical Characteristics of Prostate Cancer in India: Insights from Hospital-Based Cancer Registries.

IF 0.7 Q4 ONCOLOGY
Indian Journal of Surgical Oncology Pub Date : 2026-09-01 Epub Date: 2026-02-21 DOI:10.1007/s13193-026-02551-5
Gunaseelan Karunanidhi, Pooja Sethi, Anita Nath, Kondalli Lakshminarayan Sudarshan, Thilagavathi Ramamoorthy, Abhishek David George, Prashant Mathur
{"title":"Clinical Characteristics of Prostate Cancer in India: Insights from Hospital-Based Cancer Registries.","authors":"Gunaseelan Karunanidhi, Pooja Sethi, Anita Nath, Kondalli Lakshminarayan Sudarshan, Thilagavathi Ramamoorthy, Abhishek David George, Prashant Mathur","doi":"10.1007/s13193-026-02551-5","DOIUrl":null,"url":null,"abstract":"<p><p>To analyse the clinicopathological characteristics of prostate cancer using data from Hospital Based Cancer Registries (HBCRs) under India's National Cancer Registry Programme (NCRP), providing real-world insights into its management across health care institutions despite existing standardised treatment guidelines. We conducted a descriptive analysis of prostate cancer, examining key parameters such as age, diagnostic techniques, primary histological classification (categorised using the ICD -O3), disease stage at presentation(localised, loco regional, or distant metastasis), treatment intent modalities and the time interval between diagnosis and treatment initiation, utilising the data from Hospital Based Cancer Registries(HBCRs). 75.6% of total prostate cancer cases occurred in the age group of 60-80 years. Adenocarcinoma was the most common pathology, constituting 77% of cases. At the time of presentation, 57% of cases were diagnosed with localised (29.9%) or locoregional (27%) cancer, while 43% of patients presented with distant metastasis. Thirty per cent underwent surgical treatment, and 22% received radiation therapy. Systemic therapy was the most common single modality treatment. Our study indicates that over 80% of patients commence treatment within two months of diagnosis, but referral systems and delays in care persist. To address these challenges, the healthcare system must prioritise improving referral efficiency, reducing administrative bottlenecks, enhancing coordination through digital health records, and multidisciplinary tumour boards.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"17 9","pages":"2203-2209"},"PeriodicalIF":0.7000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13620008/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Surgical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13193-026-02551-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/21 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

To analyse the clinicopathological characteristics of prostate cancer using data from Hospital Based Cancer Registries (HBCRs) under India's National Cancer Registry Programme (NCRP), providing real-world insights into its management across health care institutions despite existing standardised treatment guidelines. We conducted a descriptive analysis of prostate cancer, examining key parameters such as age, diagnostic techniques, primary histological classification (categorised using the ICD -O3), disease stage at presentation(localised, loco regional, or distant metastasis), treatment intent modalities and the time interval between diagnosis and treatment initiation, utilising the data from Hospital Based Cancer Registries(HBCRs). 75.6% of total prostate cancer cases occurred in the age group of 60-80 years. Adenocarcinoma was the most common pathology, constituting 77% of cases. At the time of presentation, 57% of cases were diagnosed with localised (29.9%) or locoregional (27%) cancer, while 43% of patients presented with distant metastasis. Thirty per cent underwent surgical treatment, and 22% received radiation therapy. Systemic therapy was the most common single modality treatment. Our study indicates that over 80% of patients commence treatment within two months of diagnosis, but referral systems and delays in care persist. To address these challenges, the healthcare system must prioritise improving referral efficiency, reducing administrative bottlenecks, enhancing coordination through digital health records, and multidisciplinary tumour boards.

印度前列腺癌的临床特征:来自医院癌症登记处的见解。
利用印度国家癌症登记计划(NCRP)下基于医院的癌症登记处(HBCRs)的数据分析前列腺癌的临床病理特征,在现有标准化治疗指南的情况下,为跨卫生保健机构的前列腺癌管理提供真实的见解。我们对前列腺癌进行了描述性分析,检查了关键参数,如年龄、诊断技术、主要组织学分类(使用ICD -O3分类)、首发时的疾病分期(局部、局部或远处转移)、治疗意图模式以及诊断和开始治疗之间的时间间隔,利用了基于医院的癌症登记处(hbcr)的数据。75.6%的前列腺癌病例发生在60-80岁年龄组。腺癌是最常见的病理,占77%的病例。在出现时,57%的病例被诊断为局部(29.9%)或局部区域(27%)癌症,而43%的患者被诊断为远处转移。30%接受了手术治疗,22%接受了放射治疗。全身治疗是最常见的单一治疗方式。我们的研究表明,超过80%的患者在诊断后两个月内开始治疗,但转诊系统和护理延误仍然存在。为了应对这些挑战,医疗保健系统必须优先考虑提高转诊效率,减少管理瓶颈,通过数字健康记录和多学科肿瘤委员会加强协调。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
190
期刊介绍: The Indian Journal of Surgical Oncology aims to encourage and promote clinical and research activities pertaining to Surgical Oncology. It also aims to bring in the concept of multidisciplinary team approach in management of various cancers. The Journal would publish original article, point of technique, review article, case report, letter to editor, profiles of eminent teachers, surgeons and instititions - a short (up to 500 words) of the Cancer Institutions, departments, and oncologist, who founded new departments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书